MarjorieGreenMD

Breast Cancer, Hematologic Oncology

SVP, Late Stage Clinical Development

Dr. Green is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1998 - 2001
University of Virginia Medical CenterResidency, Internal Medicine, 1995 - 1998
University of Texas Medical Branch School of MedicineClass of 1995

Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with PembrolizumabDecember 16th, 2024
Merck Receives Positive EU CHMP Opinion for WELIREG® (Belzutifan) as Treatment for Adult Patients with Certain Types of Von Hippel-Lindau Disease-Associated Tumors and for Certain Previously Treated Adult Patients with Advanced Renal Cell CarcinomaDecember 13th, 2024
Seagen Announces U.S. FDA Approval of New Indication for ADCETRIS® (Brentuximab Vedotin) for Children with Previously Untreated High Risk Hodgkin LymphomaNovember 10th, 2022
Join now to see all